QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 215 filers reported holding QIAGEN NV in Q4 2017. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $799,057 | +20.9% | 17,745 | +23.4% | 0.13% | -4.3% |
| Q1 2023 | $660,703 | -17.9% | 14,385 | -10.8% | 0.14% | -34.3% |
| Q4 2022 | $804,603 | +151.4% | 16,134 | +147.4% | 0.21% | +388.4% |
| Q1 2022 | $320,000 | -66.4% | 6,522 | -61.9% | 0.04% | -74.7% |
| Q4 2021 | $951,000 | +162.7% | 17,114 | +144.0% | 0.17% | +385.7% |
| Q3 2021 | $362,000 | +10.7% | 7,014 | +3.9% | 0.04% | -23.9% |
| Q2 2021 | $327,000 | +6.2% | 6,752 | -6.2% | 0.05% | -79.6% |
| Q2 2020 | $308,000 | -83.0% | 7,200 | -83.9% | 0.22% | +136.8% |
| Q2 2019 | $1,809,000 | +266.9% | 44,615 | +242.8% | 0.10% | +216.7% |
| Q3 2018 | $493,000 | -85.8% | 13,015 | -87.9% | 0.03% | -89.5% |
| Q1 2018 | $3,483,000 | +152.9% | 107,800 | +146.7% | 0.29% | +70.8% |
| Q3 2017 | $1,377,000 | +425.6% | 43,700 | +460.3% | 0.17% | +342.1% |
| Q2 2017 | $262,000 | – | 7,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
| Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
| Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
| Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
| RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
| SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
| FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
| Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
| Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |